Altimmune, Inc. - ALT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 04, 2026 | — | A | A | 160,000.0 | 0.0 | 0.0 | 160,000.0 | View | |
| Nov 04, 2026 | — | A | A | 160,000.0 | 0.0 | 0.0 | 160,000.0 | View | |
| Oct 05, 2026 | Chief Medical Officer | M | D | 37,500.0 | 0.0 | 0.0 | 112,500.0 | View | |
| Oct 05, 2026 | Chief Medical Officer | F | D | 12,679.0 | 2.76 | 34,994.04 | 24,821.0 | View | |
| Oct 05, 2026 | Chief Medical Officer | M | A | 37,500.0 | 0.0 | 0.0 | 37,500.0 | View | |
| Oct 05, 2026 | Chief Financial Officer | M | D | 14,475.0 | 0.0 | 0.0 | 43,425.0 | View | |
| Oct 05, 2026 | Chief Financial Officer | F | D | 4,379.0 | 2.76 | 12,086.04 | 49,927.0 | View | |
| Oct 05, 2026 | Chief Financial Officer | M | A | 14,475.0 | 0.0 | 0.0 | 54,306.0 | View | |
| Oct 02, 2026 | Principal Accounting Officer | A | A | 36,234.0 | 0.0 | 0.0 | 36,234.0 | View | |
| Oct 02, 2026 | Principal Accounting Officer | A | A | 84,546.0 | 0.0 | 0.0 | 84,546.0 | View | |
| Sep 17, 2026 | Chief Commercial Officer | M | D | 24,000.0 | 0.0 | 0.0 | 72,000.0 | View | |
| Sep 17, 2026 | Chief Commercial Officer | F | D | 6,826.0 | 3.24 | 22,116.24 | 17,174.0 | View | |
| Sep 17, 2026 | Chief Commercial Officer | M | A | 24,000.0 | 0.0 | 0.0 | 24,000.0 | View | |
| Aug 13, 2026 | President and CEO | P | A | 15,000.0 | 2.95 | 44,250.0 | 62,500.0 | View | |
| Aug 03, 2026 | Chief Scientific Officer | A | A | 875.0 | 2.414 | 2,112.25 | 113,699.0 | View | |
| Aug 03, 2026 | Chief Financial Officer | A | A | 1,753.0 | 2.414 | 4,231.74 | 39,831.0 | View |